EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ten years of injectable platelet‐rich fibrin

Richard J Miron, Reinhard Gruber iD, Nima Farshidfar, Anton Sculean, Yufeng Zhang iD

Periodontology 2000 · 2024-02 · 94 (1) · 92-113

DOI: 10.1111/prd.12538 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Periodontology 2000, online erschienen am 30.11.2023. Verfasst von Richard J Miron und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of platelet‐rich fibrin (PRF) has seen widespread advantages over platelet‐rich plasma (PRP) in many fields of medicine. However, until 2014, PRF remained clinically available only in its solid clotted form. Modifications to centrifugation protocols and tube technology have led to the development of a liquid injectable version of PRF (i‐PRF). This narrative review takes a look back at the technological developments made throughout the past decade and further elaborates on their future clinical applications. Topics covered include improvements in isolation techniques and protocols, ways to further concentrate i‐PRF, and the clinical impact and relevance of cooling i‐PRF. Next, various uses of i‐PRF are discussed, including its use in regenerative periodontology, implantology, endodontics, temporomandibular joint injections, and orthodontic tooth movement. Furthermore, various indications in medicine are also covered, including its use in sports injuries and osteoarthritis of various joints, treatment of diabetic ulcers/wound care, and facial esthetics and hair regrowth. Finally, future applications are discussed, mainly its use as a drug delivery vehicle for small biomolecules, such as growth factors, antibiotics, exosomes, and other medications that may benefit from the controlled and gradual release of biomolecules over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich FibrinHumansInjections

Stichwörter der Autor:innen

L‐PRFhorizontal centrifugationplatelet‐rich fibrintissue regenerationwound healing

Autor:innen und Institutionen

  • Department of Periodontology, University of Bern, Bern, Switzerland.
  • Department of Oral Biology, Medical University of Vienna, Vienna, Austria.
  • Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Department of Oral Implantology, University of Wuhan, Wuhan, China.

ORCID-Profile: Reinhard Gruber, Yufeng Zhang

Zitieren

APA

Miron, R. J., Gruber, R., Farshidfar, N., Sculean, A., & Zhang, Y. (2024). Ten years of injectable platelet‐rich fibrin. Periodontology 2000, 94(1), 92-113. https://doi.org/10.1111/prd.12538

Vancouver

Miron RJ, Gruber R, Farshidfar N, Sculean A, Zhang Y. Ten years of injectable platelet‐rich fibrin. Periodontology 2000. 2024;94(1):92-113. doi:10.1111/prd.12538

BibTeX
@article{Miron2024,
  author = {Miron, Richard J and Gruber, Reinhard and Farshidfar, Nima and Sculean, Anton and Zhang, Yufeng},
  title = {Ten years of injectable platelet‐rich fibrin},
  journal = {Periodontology 2000},
  year = {2024},
  volume = {94},
  number = {1},
  pages = {92--113},
  doi = {10.1111/prd.12538}
}
Kostenlos starten →